Pharma-Bio Serv Inc. Stock , PBSV

	2023	2024	2025
Revenue	21	28	30
Dividend	-	-	-
Dividend Yield (in %)	-	-	-
EPS	0.10	0.14	0.16
P/E Ratio	10.40	7.43	6.50
EBIT	3	4	4
EBITDA	3	4	4
Net Profit	3	3	4
Net Profit Adjusted	-	-	-
Pre-Tax Profit	3	4	4
Net Profit (Adjusted)	-	-	-
EPS (Non-GAAP) ex. SOE	-	-	-
EPS (GAAP)	-	-	-
Gross Income	8	9	9
Cash Flow from Investing	0	0	0
Cash Flow from Operations	2	3	3
Cash Flow from Financing	-1	-1	-1
Cash Flow per Share	-	-	-
Free Cash Flow	-	-	-
Free Cash Flow per Share	-	-	-
Book Value per Share	-	-	-
Net Debt	-	-	-
Research & Development Exp.	-	-	-
Capital Expenditure	0	0	0
Selling, General & Admin. Exp.	5	5	5
Shareholder’s Equity	25	28	31
Total Assets	33	35	38

	Previous Quarter	Current Quarter ending 01/31/23	Next Quarter ending 04/30/23	Current Year ending 10/31/23	Next Year ending 10/31/24
Earnings Estimates
No. of Analysts	-	-	-	1	1
Average Estimate	-	-	-	0.100 USD	0.140 USD
Year Ago	-	-	-	-	0.100 USD
Publish Date	-	-	-	-	-
Revenue Estimates
No. of Analysts	-	1	1	1	1
Average Estimate	-	5 USD	5 USD	21 USD	28 USD
Year Ago	-	-	-	-	21 USD
Publish Date	-	3/20/2023	6/14/2023	-	-

* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Pharma-Bio Serv Insider Activity

Name	Date	shares traded	shares held	Price	type (sell/buy)	option
Sanchez Altura Victor	03/05/2023	7,167.00	11,382.00	1.15	Sell	No
LASANTA PEDRO J	03/05/2023	7,167.00	119,188.00	1.15	Sell	No
LASANTA PEDRO J	03/05/2023	76,522.00	118,030.00	1.15	Sell	No
Sanchez Altura Victor	03/05/2023	8,325.00	18,549.00	0.99	Buy	No
LASANTA PEDRO J	03/05/2023	8,325.00	126,355.00	0.99	Buy	No
LASANTA PEDRO J	03/05/2023	100,000.00	194,552.00	0.88	Buy	No
SPINDEL HOWARD	01/08/2023	6,835.00	n/a	n/a	Sell	No
SPINDEL HOWARD	01/08/2023	13,165.00	6,835.00	0.79	Sell	No
SPINDEL HOWARD	01/08/2023	6,835.00	41,372.00	n/a	Buy	No
SPINDEL HOWARD	01/08/2023	20,000.00	20,000.00	0.52	Buy	No
Perlysky Dov	01/03/2022	5,049.00	44,288.00	1.03	Sell	No
Perlysky Dov	01/03/2022	17,670.00	39,337.00	1.03	Sell	No
WIESEN IRVING L	01/03/2022	10,097.00	44,335.00	1.03	Sell	No
WIESEN IRVING L	01/03/2022	17,670.00	34,432.00	1.03	Sell	No
SPINDEL HOWARD	01/03/2022	2,330.00	n/a	n/a	Sell	No
SPINDEL HOWARD	01/03/2022	17,670.00	2,330.00	1.03	Sell	No
MICHEL KIRK WHEELER	01/03/2022	17,670.00	35,036.00	1.03	Sell	No
Perlysky Dov	01/03/2022	10,000.00	49,337.00	0.52	Buy	No
Perlysky Dov	01/03/2022	20,000.00	57,007.00	0.91	Buy	No
WIESEN IRVING L	01/03/2022	20,000.00	54,432.00	0.52	Buy	No
WIESEN IRVING L	01/03/2022	20,000.00	52,102.00	0.91	Buy	No
SPINDEL HOWARD	01/03/2022	2,330.00	34,537.00	n/a	Buy	No
MICHEL KIRK WHEELER	01/03/2022	20,000.00	52,706.00	0.91	Buy	No
SPINDEL HOWARD	01/03/2022	20,000.00	20,000.00	0.91	Buy	No
PLAZA ELIZABETH	06/24/2021	100.00	3,852,921.00	1.27	Sell	No

Pharma-Bio Serv Dividend Calendar

Date	Name	Dividend	*yield	Currency
2022	Pharma-Bio Serv Inc.	-	-	USD
2021	Pharma-Bio Serv Inc.	-	-	USD
2020	Pharma-Bio Serv Inc.	-	-	USD
2019	Pharma-Bio Serv Inc.	-	-	USD
2018	Pharma-Bio Serv Inc.	0.07	7.14	USD
2017	Pharma-Bio Serv Inc.	-	-	USD
2016	Pharma-Bio Serv Inc.	-	-	USD
2015	Pharma-Bio Serv Inc.	-	-	USD
2014	Pharma-Bio Serv Inc.	-	-	USD
2013	Pharma-Bio Serv Inc.	-	-	USD
2012	Pharma-Bio Serv Inc.	-	-	USD
2011	Pharma-Bio Serv Inc.	-	-	USD
2010	Pharma-Bio Serv Inc.	-	-	USD
2009	Pharma-Bio Serv Inc.	-	-	USD

*Yield of the Respective Date

Pharma-Bio Serv Inc. Past Events

Event	Actual EPS	Info	Date

Pharma-Bio Serv Profile

Pharma-Bio Serv, Inc. engages in the provision of technical compliance consulting service and microbiological and chemical laboratory testing services to the pharmaceutical, chemical, medical device and biotechnology industries. It operates through the following business segments: Puerto Rico Technical Compliance Consulting; United States Technical Compliance Consulting; and Europe Technical Compliance Consulting. The company was founded in February 1993 and is headquartered in Dorado, Puerto Rico.

Moody’s Daily Credit Risk Score

Risk

Low
Medium
High

Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Pharma-Bio Serv Shareholder

Owner	in %
Freefloat	35.33
Elizabeth Plaza	16.79
David Selengut	13.65
Ramon L. Dominguez	8.98
Addison M. Levi	8.93
Dov Perlysky, MBA	8.63
Adam Hirsh	5.11
Kirk Wheeler Michel, MBA	1.64

Shareholder percentage totals can add to more than 100% because some holders are included in the free float.